Pharmaceutical

Valneva pushes FDA approval date for chikungunya vaccine

The PDUFA date has been pushed by three months to November to allow for more time for Phase IV activities.

Aug 14, 2023 - 20:00
Valneva pushes FDA approval date for chikungunya vaccine
The PDUFA date has been pushed by three months to November to allow for more time for Phase IV activities.
Read the original article

Tags:

Previous Article

LifeArc invests nearly $10m in Crick Institute’s Africa Scheme

Next Article

Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

U.S. government spent more on health care in 2022 than six countries with universal health care combined

U.S. government spent more on health care in 2022 than ...

Dec 19, 2023

Risk adjusted net present value: What is the current va...

Dec 15, 2024

STAT+: HCA says smaller share of spending going to labor

STAT+: HCA says smaller share of spending going to labor

Jul 28, 2023